Answers are grounded in this paper and cite their sources.
Objectives: Accumulating evidence indicates that circular RNAs (circRNAs) are critical regulators in the pathogenesis and therapeutic response of hematological malignancies. However, the functional relevance of circRNAs in nucleophosmin 1 (NPM1)-mutated acute myeloid leukemia (AML) remains incompletely understood. This study aimed to investigate the role of hsa_circ_0008135 in NPM1-mutated AML. Methods: Screening of circRNA microarray datasets was conducted to determine differentially expressed circRNAs in NPM1-mutated AML patients. In vitro loss-of-function assays were used to examine the influence of hsa_circ_0008135 on the proliferation and ferroptosis of leukemia cells. The miR-145-5p/MUC1 axis was examined by luciferase reporter analysis and rescue validation experiments. Results: hsa_circ_0008135 was significantly overexpressed in NPM1-mutated AML, and its expression was associated with poorer prognosis in this AML subtype. Silencing of hsa_circ_0008135 exerted inhibitory effects on cell proliferation and promoted ferroptosis. Mechanistically, hsa_circ_0008135 acted as a molecular sponge for miR-145-5p, which directly bound to MUC1. Accordingly, hsa_circ_0008135 inhibition decreased MUC1 expression, an effect that was reversed by miR-145-5p co-transfection. Rescue experiments further confirmed that hsa_circ_0008135 knockdown attenuated the malignant characteristics of NPM1-mutated AML cells through the miR-145-5p/MUC1 axis. Conclusions: These findings elucidate a circRNA-mediated regulatory mechanism in NPM1-mutated AML and identify potential therapeutic targets for this disease.
No takes yet. Share an insight, caveat, or question.
Jing et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: